Physician profile
Richard Park
NPI 1174718134
$726.43
in general payments reported to CMS, 2019-2025
17 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $16.20 · 2021: $88.92 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $166.78 | 2025 | Repatha, Repatha, Otezla |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $145.64 | 2019-2025 | Lifevest |
| Abiomed | $105.12 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $77.59 | 2019 | |
| Lilly USA, LLC | $54.93 | 2025 | Mounjaro, Zepbound, Kisunla |
| Abbvie INC. | $34.87 | 2025 | |
| Exact Sciences Corporation | $33.17 | 2025 | The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $29.13 | 2025 | Shingrix, Arexvy |
| Dexcom, INC. | $28.25 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $26.14 | 2025 | |
| Abbott Laboratories | $24.81 | 2025 | Id Now Instrument |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.